Oxazolidinone-quinolone hybrid antibiotics
Details for Australian Patent Application No. 2004299278 (hide)
International Classifications
Event Publications
27 July 2006 PCT application entered the National Phase
PCT publication WO2005/058888 Priority application(s): WO2005/058888
17 March 2011 Application Accepted
Published as AU-B-2004299278
12 May 2011 Corrigenda
Applications Accepted - Name Index Under the name Morphochem Aktiengesellschaft Fur Kombinatorische Chemie, Application No. 2004299278, under INID (71) correct the applicant name to Morphochem Aktiengesellschaft fuer Kombinatorische Chemie
7 July 2011 Opposition Lodged
Actelion Pharmaceuticals Ltd has lodged an opposition against Morphochem Aktiengesellschaft fuer Kombinatorische Chemie.
19 January 2012 Opposition Withdrawn
The opposition by Actelion Pharmaceuticals Ltd against Morphochem Aktiengesellschaft fuer Kombinatorische Chemie has been withdrawn.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004299279-Biological active blood serum obtained by electrostimulation
2004299277-Pyrazolo (3,4-b) pyridine compounds, and their use as phosphodiesterase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser